Protective activity of Ingavirin® in experimental lethal influenza due to pandemic influenza Virus A (H1N1)v (albino mice)

Antibiotiki i Khimioterapiya

Volumn 55, Issue 5-6, 2010, Pages 24-31

  Zarubaev, V V ^a   Garshinina, A V ^a   Kalinina, N A ^a   Shtro, A A ^a   Belyaevskaya, S V ^a   Nebolsin, V E ^b   Kiselev, O I ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b JSC Valenta Pharm   (Russian Federation)

Author keywords

Albino mice; Influenza virus A(H1N1); Ingavirin

Indexed keywords

AMIDE; ANTIVIRUS AGENT; DICARBOXYLIC ACID; IMIDAZOLE DERIVATIVE; PENTANEDIOIC ACID IMIDAZOLYL ETHANAMIDE;

ANIMAL; ARTICLE; DRUG EFFECT; FEMALE; INFLUENZA VIRUS A H1N1; LUNG; MORTALITY; MOUSE; ORTHOMYXOVIRUS INFECTION; PATHOLOGY; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

AMIDES; ANIMALS; ANTIVIRAL AGENTS; DICARBOXYLIC ACIDS; FEMALE; IMIDAZOLES; INFLUENZA A VIRUS, H1N1 SUBTYPE; LUNG; MICE; ORTHOMYXOVIRIDAE INFECTIONS; VIRUS REPLICATION;

INFLUENZAVIRUS A; MUS; ORTHOMYXOVIRIDAE;

EID: 77957197836     PISSN: 02352990     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Ghendon Y. Influenza -its impact and control. World Health Statistic Q 1992; 45: 306-311.
2. Zambon M. C. Epidemiology and pathogenesis of influenza. J Antimicrob Chemother 1999; 44: Suppl B: 3-9.
3. Scholtissek C., Quack G., Klenk H. D., Webster R. G. Antiviral Res 1998; 37: 83.
4. Woodhead M., Lavanchy D., Johnston S. et al. Neuraminidase inhibitors: progress in the management of influenza. Int J Clin Pract 2000 Nov; 54: 9: 604-610.
5. Kakugawa S., Shimojima M., Neumann G. et al. RuvB-like protein 2 is a suppressor of influenza A virus polymerases. J Virol 2009 Jul; 83: 13: 6429-6434.
6. Ludwig S., Planz O., Pleschka S., Wolff T. Influenza-virus-induced signalling cascades: targets for antiviral therapy? Trends in Molecular Medicine 2003; 9: 46-52.
7. Naveen Kumar, Zhong-tao Xin, Yuhong Liang et al. Signalling differentially regulates influenza virus RNA synthesis. J Virol 2008; 82: 20: 9880-9889.
8. David S. Fedson. Confronting the next influenza pandemic with antiinflammatory and immunomodulatory agents: why they are needed and how they might work. Influenza and other Respiratory Viruses 3: 129-142.